Toolkit for Communicating Clinical Trial Results: Activities & Timing: Best Practice Summary

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

This document contains an introduction and 13 graphics that outline the key steps in the process of communicating clinical trial results to physicians, the managed care community and consumers. It outlines specific activities recommended at each phase of a clinical study as well as pre-clinical and post-launch activities. The process of communicating clinical study results requires prioritization of key activities and careful coordination to ensure a long-lasting effect in the minds of these key audiences. Reading this document will allow you to carefully plan when each activity should start and end throughout the development process. This document is compiled from research done as part of Best Practices, LLC's consulting services.

Industries Profiled:
Pharmaceutical; Biotech; Health Care

Companies Profiled:
Abbott Laboratories; Sanofi-aventis; AstraZeneca; Bristol-Myers Squibb; Eli Lilly; GlaxoSmithKline; Janssen; Merck; Pharmacia; Novartis; Schering-Plough

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

Toolkit for Communicating Clinical Trial Results: Activities & Timing

ID: 4428

Features:

Published: Pre-2019

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3jandj
4/bestp
5/bestp/domrep.nsf
658052DA1DD6BD7B185256D3300804840
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/toolkit-for-communicating-clinical-trial-results-activities-timing?opendocument
18
19
20
21
22
23
24/bestp/domrep.nsf
25DB